Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Patient-Paired Sample Congruence Between 2 Commercial Liquid Biopsy Tests.

Literature DB >> 29242909

Patient-Paired Sample Congruence Between 2 Commercial Liquid Biopsy Tests.

Gonzalo Torga¹, Kenneth J Pienta¹.

Abstract

Entities: Species

Mesh：

Substances：

Year: 2018 PMID： 29242909 PMCID： PMC6145681 DOI： 10.1001/jamaoncol.2017.4027

Source DB: PubMed Journal: JAMA Oncol ISSN： 2374-2437 Impact factor: 31.777

× No keyword cloud information.

6 in total

1. Limits to Personalized Cancer Medicine.

Authors: Ian F Tannock; John A Hickman
Journal: N Engl J Med Date: 2016-09-29 Impact factor: 91.245

2. The cancer bloodhounds.

Authors: Sarah Webb
Journal: Nat Biotechnol Date: 2016-11-08 Impact factor: 54.908

Review 3. Liquid biopsies come of age: towards implementation of circulating tumour DNA.

Authors: Jonathan C M Wan; Charles Massie; Javier Garcia-Corbacho; Florent Mouliere; James D Brenton; Carlos Caldas; Simon Pacey; Richard Baird; Nitzan Rosenfeld
Journal: Nat Rev Cancer Date: 2017-02-24 Impact factor: 60.716

4. Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients.

Authors: Maria Schwaederle; Hatim Husain; Paul T Fanta; David E Piccioni; Santosh Kesari; Richard B Schwab; Sandip P Patel; Olivier Harismendy; Megumi Ikeda; Barbara A Parker; Razelle Kurzrock
Journal: Clin Cancer Res Date: 2016-05-16 Impact factor: 12.531

5. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing.

Authors: Rebecca J Leary; Mark Sausen; Isaac Kinde; Nickolas Papadopoulos; John D Carpten; David Craig; Joyce O'Shaughnessy; Kenneth W Kinzler; Giovanni Parmigiani; Bert Vogelstein; Luis A Diaz; Victor E Velculescu
Journal: Sci Transl Med Date: 2012-11-28 Impact factor: 17.956

6. Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA.

Authors: Richard B Lanman; Stefanie A Mortimer; Oliver A Zill; Dragan Sebisanovic; Rene Lopez; Sibel Blau; Eric A Collisson; Stephen G Divers; Dave S B Hoon; E Scott Kopetz; Jeeyun Lee; Petros G Nikolinakos; Arthur M Baca; Bahram G Kermani; Helmy Eltoukhy; AmirAli Talasaz
Journal: PLoS One Date: 2015-10-16 Impact factor: 3.240

6 in total

60 in total

1. Low clinical adoption of tumor genomic profiling: cause for concern?

Authors: Michael W Drazer; Randy F Sweis
Journal: J Med Econ Date: 2018-05-15 Impact factor: 2.448

Review 2. Liquid Biopsy to Identify Actionable Genomic Alterations.

Authors: Sai-Hong Ignatius Ou; Misako Nagasaka; Viola W Zhu
Journal: Am Soc Clin Oncol Educ Book Date: 2018-05-23

Review 3. Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA).

Authors: Re-I Chin; Kevin Chen; Abul Usmani; Chanelle Chua; Peter K Harris; Michael S Binkley; Tej D Azad; Jonathan C Dudley; Aadel A Chaudhuri
Journal: Mol Diagn Ther Date: 2019-06 Impact factor: 4.074

4. From Somatic Variants Toward Precision Oncology: An Investigation of Reporting Practice for Next-Generation Sequencing-Based Circulating Tumor DNA Analysis.

Authors: Rongxue Peng; Rui Zhang; Martin P Horan; Li Zhou; Sze Yee Chai; Nalishia Pillay; Kwang Hong Tay; Tony Badrick; Jinming Li
Journal: Oncologist Date: 2019-08-30

10. From Somatic Variants Toward Precision Oncology: An Investigation of Reporting Practice for Next-Generation Sequencing-Based Circulating Tumor DNA Analysis.